2012 IoN News Archive
- Hereditary Whispering Dystonia gene identified
- Belgian Stroke Council Award to UCL student
- Professor Nicholas Wood appointed as neuroscience programme director for UCLH NIHR Biomedical Research Centre (BRC)
- UCL neuroscientists awarded highly competitive ERC Advanced Grants
- Drugs could provide new treatment for epilepsy
- Breakthrough in the treatment of drug-resistant epilepsy
- UCL Institute of Neurology enters gene-editing research collaboration with Horizon Discovery
- Lifetime achievement award for Professor Thompson’s MS work
- New biography of Gowers released
- Repurposed cardiac sodium channel blocker brings significant benefit for patients with a rare neuromuscular disease
- Toxic protein build-up in blood shines light on fatal brain disease
- Professor Lees receives prestigious German Society of Neurology award
- Cause of Alternating Hemiplegia identified
- Dr John Morgan-Hughes
- Results from stroke treatment study are in top 10 of Lancet’s most highly cited papers
- Skin patch improves attention span in stroke patients
- Genetic study identifies treatable pathway in childhood motor neuron disease
- Awards and congratulations
- Medical Photographer Wins Wellcome Image Awards
- Prestigious Junior Investigator Award for stroke research
- Unlocking the mysteries of the mind
- Official unveiling of Neuroimaging Centre
- Professor Simon Shorvon appointed Harveian librarian at the Royal College of Physicians
- Parliamentary Group Visit the Institute
- Cultural Consultation Service website launches
- Clinical Teaching Awards 2011/12
- Prestigious European Science Foundation networking grant awarded to Institute of Neurology professor
- International project to determine vascular contribution to neurodegeneration begins
- Prime Minister visits UCL Institute of Neurology
- Professor Ray Dolan gives the prestigious Alan Turing Lecture
- The Performing Brain – A moving story? Friday 16th March
- Are we hard wired to be rebellious?
- Detecting stroke
- Queen Square Clinical Trial Centre launched
- New funding to preserve unique archives
- Major new funding for research into epilepsy is announced
- Professor Ray Dolan elected Fellow of the APS
- New Years Honours
- Brain Implant Cures Woman's Tourette's Tics
Published: Oct 22, 2014 9:52:00 AM
Published: Sep 16, 2013 1:37:21 PM
Published: Jan 21, 2015 12:20:24 PM
Published: Feb 24, 2014 2:53:53 PM
Effects of expertise, normal aging and psychological illness on our ability to monitor for processing conflicts and errors
Published: Dec 8, 2014 1:08:44 PM
Published: Jan 14, 2015 12:07:19 PM
Prime Minister visits UCL Institute of Neurology
27 March 2012
UK Prime Minister David Cameron has visited the Dementia Research Centre at UCL as part of this morning’s government announcement that dementia research funding will be doubled to £66 million by 2015.
The Prime Minister visited the Centre, part of UCL Institute of Neurology, as well as partner hospital the National Hospital for Neurology and Neurosurgery (NHNN). He spoke to clinicians and academics about their work, as well as patients involved in UCL research.
Referring to dementia as “one of the greatest challenges of our time”, Mr Cameron said: "We've got to treat this like the national crisis it is. We need an all-out fightback against this disease, one that cuts across society. This is a personal priority of mine, and it's got an ambition to match. That ambition – nothing less than for Britain to be a world leader in dementia research and care."
Professor Michael Hanna, Director of the UCL Institute of Neurology, who met the Prime Minister today, said: “Neuroscience research at UCL is already of world-leading quality – but faced with the enormous challenge of dementia, excellent neuroscience needs to translate into new therapies.
There are world class research teams at the UCL Institute of Neurology who are developing new experimental treatments for dementia and this critical mass of expertise is set to increase in coming years.
Professor Michael Hanna, Director of the UCL Institute of Neurology
“There are world class research teams at the UCL Institute of Neurology who are developing new experimental treatments for dementia and this critical mass of expertise is set to increase in coming years. We share the Prime Minister’s ambition to place the UK at the very forefront of medical research in this area, helping to find treatments for patients. Any initiative that will help in achieving this goal is to be applauded.”
Professor Martin Rossor, UCL Institute of Neurology, said: “We were pleased to welcome David Cameron to the Dementia Research Centre today to tell him more about our research. In particular, we discussed the challenge of early and accurate diagnosis of the causes of dementia and this access to prompt, accurate diagnosis is something the prime minister emphasised in his speech. It is excellent news that the government has pledged more money for this area of research, which is so desperately needed.”
UCL scientists are at the forefront of dementia research, working closely with clinicians at partner hospital the NHNN, part of University College London NHS Foundation Trust. This partnership brings together clinical and scientific excellence in the search for effective diagnosis and treatment for devastating neurological diseases.
UCL is Europe’s research powerhouse in neuroscience – ranked second in the world, and first in Europe, in neuroscience and behaviour by Thomson ISI Essential Science Indicators, and with more than twice as many publications and citations as any other European institution.
Neuroscience is a strategic priority for UCL, spearheaded by the new Faculty of Brain Sciences. UCL recently received a £20million grant from the Wolfson Foundation to establish The Leonard Wolfson Experimental Neurology Centre at Queen Square, which will be dedicated to the understanding and treatment of neurodegenerative diseases. This is the largest single award ever made by the Foundation and one of the largest philanthropic donations in the university’s history.
The Centre will accelerate the development of treatments and identify future therapeutic targets for neurodegenerative diseases, with the aim of earlier intervention for patients.
Media contact: David Weston
Image caption: (l-to-r) Professor Martin Rossor, Prime Minister David Cameron and patient David Hague.
Page last modified on 27 mar 12 12:11